MedPath

Infusion of drugs in the wound for pain relief.

Not Applicable
Completed
Conditions
Health Condition 1: K318- Other specified diseases of stomach and duodenum
Registration Number
CTRI/2020/07/026282
Lead Sponsor
AIIMS Bhubaneswar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

All patients aged between 18-85 years, planned for midline laparotomy for gastric carcinoma or benign gastric outlet obstruction.

Exclusion Criteria

Patients with peritonitis, chronic use of analgesics, history of drugs or alcohol abuse, neuropsychiatric disorders, ASA grade 4, known allergy to study drug, diabetics, cardiorespiratory compromise, on thrombolytic therapy, patients requiring post operative mechanical ventilation or sedation, contraindication to epidural anaesthesia and failed to understand or sign the informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of ropivacaine and rescue analgesic consumption up to twenty four hour following surgery <br/ ><br>Timepoint: Amount of ropivacaine and rescue analgesic consumption up to twenty four hour following surgery <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Differences in analgesia as measured by visual analogue score, <br/ ><br>local wound side effects within 7 days after surgery as classified by Clavien Dindo score, <br/ ><br>passage of first flatus, <br/ ><br>day of out of bed mobilization, <br/ ><br>patient satisfaction as measured by a four-point rating scale of 1: poor, 2: fair, 3: good, and 4: excellent.Timepoint: 7 days
© Copyright 2025. All Rights Reserved by MedPath